Endomag
Endomag is a global technology company that believes everyone deserves a better standard of cancer care. Founded as a spin-out from University College London (UCL) and the University of Houston in 2007, Endomag continues to develop its innovative clinical platform that uses magnetic fields to power diagnostic and therapeutic devices.
At Endomag, we believe everyone deserves a better standard of cancer care. That’s why we design our magnetic technologies with both the clinician and patient in mind. Many leading hospitals across the world use our unique solutions to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is.
At the heart of the company’s technologies is the Sentimag® localisation system. The Sentimag® system features a probe which works like a metal detector. When it is placed near the skin’s surface, it can detect Endomag’s magnetic seed marker (Magseed®) and liquid tracer (Magtrace®), for accurate lesion localisation and sentinel lymph node biopsy procedures.
Endomag’s technologies have already helped 485,000+ women worldwide to access more precise, and minimally invasive breast cancer treatment.
![330 Cambridge Science Park [copyright – Bidwells]](/sites/default/files/styles/article_card/public/330%20Cambridge%20Science%20Park.jpg?itok=cuWs6Gno)
